Literature DB >> 28447721

Clinical significance of inflammatory cytokine and chemokine expression in hand, foot and mouth disease.

Ping Shao1, Xiaoxin Wu2, Hongbo Li3, Zhigang Wu2, Zongxin Yang3, Hangping Yao1.   

Abstract

The present study examined the relationship between cytokine and chemokine expression and the clinical presentation of hand, foot and mouth disease (HFMD), which is currently unclear. The present study involved 28 patients with mild HFMD, 44 patients with severe HFMD and 26 healthy children. Venous blood was tested for cytokine [interleukin (IL)‑4, IL‑12, IL‑18, tumor necrosis factor‑α (TNF‑α), interferon‑γ (IFN‑γ)] and chemokine expression [IL‑8, regulated on activation, normal T cell expressed and secreted (RANTES), monocyte chemoattractant protein‑1 (MCP‑1) and IFN-γ-inducible protein‑10 (IP‑10)]. Stool samples from the patients were tested for enterovirus 71 (EV71) RNA using reverse transcription-polymerase chain reaction. The results indicated that all cytokine/chemokine levels were increased in patients with severe HFMD compared with in patients with mild HFMD or control subjects. In addition, RANTES, MCP‑1, IL‑4, IL‑12 and IL‑18 levels were higher in mild HFMD patients than in the controls. In patients with severe HFMD, all expression levels (with the exception of IL‑8 and IL‑4) were increased in patients with encephalitis plus pulmonary edema compared with those with encephalitis alone. Furthermore, all levels (with the exception of IL‑8) were increased in EV71‑positive patients compared with EV71‑negative patients. In mild HFMD, all levels (with the exception of IL‑8 and IL‑4) were increased in EV71‑positive patients compared with EV71‑negative patients. However, in severe HFMD, only RANTES, IP‑10 and IFN‑γ levels were increased in EV71‑positive patients compared with EV71‑negative patients. In the EV71‑negative group, all levels were increased in severe HFMD compared with mild HFMD. In the EV71‑positive group, all levels (with the exception of IL‑8) were increased in severe HFMD compared with mild HFMD. These results indicated that cytokines and chemokines participate in HFMD pathogenesis, and may be useful to monitor disease progression and predict prognosis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28447721     DOI: 10.3892/mmr.2017.6324

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

1.  [Levels of lymphocyte subsets, immunoglobulins, and complement C3 and C4 in children with hand-foot-mouth disease].

Authors:  Xiao-Mei Liu; Zhen-Ze Cui; Shu-Jun Jing; Guang Yang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-12

2.  Cytokine and Chemokine Profiling in Patients with Hand, Foot and Mouth Disease in Singapore and Malaysia.

Authors:  Fiona Mei Shan Teo; Min Nyo; Anng Anng Wong; Natalie Woon Hui Tan; Mia Tuang Koh; Yoke Fun Chan; Chia Yin Chong; Justin Jang Hann Chu
Journal:  Sci Rep       Date:  2018-03-06       Impact factor: 4.379

3.  Association between platelet count and the risk and progression of hand, foot, and mouth disease among children.

Authors:  Li Miao; Yongjuan Liu; Peiliang Luo; Song Mao; Jiansheng Liu; Siguang Lu
Journal:  Clinics (Sao Paulo)       Date:  2020-05-15       Impact factor: 2.365

4.  Excellent Response to Plasma Exchange in Three Patients With Enterovirus-71 Neurological Disease.

Authors:  Elba Pascual-Goñi; Maria Josa; Cristian Launes; Luis Querol; Marga Del Cuerpo; M Alba Bosch; Iolanda Jordan; Eulàlia Turón-Viñas
Journal:  Front Neurol       Date:  2019-05-24       Impact factor: 4.003

5.  Total astragalosides decrease apoptosis and pyroptosis by inhibiting enterovirus 71 replication in gastric epithelial cells.

Authors:  Xiaoyan Zhang; Jinfang Hao; Chenxi Sun; Jianping Du; Qian Han; Qingshan Li
Journal:  Exp Ther Med       Date:  2022-01-24       Impact factor: 2.447

6.  Pathogenic analysis of coxsackievirus A10 in rhesus macaques.

Authors:  Suqin Duan; Fengmei Yang; Yanyan Li; Yuan Zhao; Li Shi; Meng Qin; Quan Liu; Weihua Jin; Junbin Wang; Lixiong Chen; Wei Zhang; Yongjie Li; Ying Zhang; Jingjing Zhang; Shaohui Ma; Zhanlong He; Qihan Li
Journal:  Virol Sin       Date:  2022-06-28       Impact factor: 6.947

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.